Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
The European Stroke Organisation Conference (ESOC) 2017 took place this week from 16-18 May in Prague, Czech Republic. The third day of ESOC saw some exciting late breaking clinical trials.
The European Stroke Organisation Conference (ESOC) 2017 is currently on from 16-18 May in Prague, Czech Republic.
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
Published in the journal Neuropsychologia, a new study sheds light on why some people with stroke have difficulty comprehending language.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Published in Stroke, a new study sheds light on a tool doctors might use to help them predict the recovery of stroke patients in the future.
Last week, our lecturers attended two training days at our head office, at Stroke Association House, London. These form part of a schedule of activity designed to ensure they have the skills, and support needed to succeed in becoming the next generation of research leaders.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take homes from our International Development Officer, Sarah Belson.